Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Anticancer Res ; 22(2A): 889-92, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12014667

RESUMO

BACKGROUND: Mixed-valent diruthenium tetracarboxylate complexes were shown to have slight antineoplastic activity against P388 leukemia cell lines. However these complexes suffered from poor water-solubility, which may have detrimentally affected their activity. MATERIALS AND METHODS: Mixed-valent diruthenium tetracarboxylates of the type [Ru2(O2CR)4(L)2] (PF6) with L = imidazole, 1-methylimidazole and H2O when R = CH3, L = ethanol when R = Fc (ferrocenyl) or Fc-CH=CH- and of the type M3[Ru2(O2CR)4(H2O)2]4H2O, M = Na+ when R = m-C6H4SO3- and M = K+ when R = p-C6H4SO3-, were tested for cytotoxicity against HeLa and multidrug resistant CoLo 320DM human cancer cell lines. Cell survival was measured by means of the colorometric 3-(4,5dimethylthiazol-2-yl)-diphenyltetrazodium bromide assay. RESULTS: The mean drug concentration from 3 experiments causing 50% cell killing, ie, IC50 values, varied between 120 and 950 micromol dm(-3). CONCLUSION: The antineoplastic activity of the highly water-soluble m-sulpho derivative was the highest, while the poorly water-soluble imidazole derivatives did not exhibit any cytotoxic properties. The CoLo 320DM cancer cells were 5 times more prone to drug-induced cell death than the HeLa cells.


Assuntos
Antineoplásicos/toxicidade , Compostos Organometálicos/toxicidade , Rutênio/toxicidade , Animais , Antineoplásicos/química , Ensaios de Seleção de Medicamentos Antitumorais , Células HeLa/efeitos dos fármacos , Humanos , Leucemia P388/tratamento farmacológico , Camundongos , Compostos Organometálicos/química , Rutênio/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...